尽量减少代谢和心脏风险因素,以最大限度地提高肝移植后的结果
Kathryn Schmidt1, Ashley Spann2, Mohammad Qasim Khan3
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Transplantation
|December 7, 2023
概括
心血管疾病 (CVD) 是肝移植后的主要并发症. 本综述侧重于降低心脏代谢疾病风险和降低具有代谢综合征和心血管疾病的肝移植接受者死亡率的策略.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 移植医学 移植医学
背景情况:
- 心血管疾病 (CVD) 是肝移植后的一种严重并发症.
- 关键的危险因素包括晚年,先前存在的心血管疾病,非酒精性脂肪肝疾病,慢性病和代谢综合征.
研究的目的:
- 审查目前的策略,以尽量减少心脏代谢疾病负担在肝移植接受者.
- 确定潜在的干预措施,以减少与代谢综合征和心血管疾病移植后的死亡率.
主要方法:
- 对当代策略的文学评论.
- 分析肝移植后心血管疾病的危险因素.
- 对代谢综合征和心血管疾病的干预区域的探索.
主要成果:
- 确定导致肝移植后心血管疾病的主要风险因素.
- 概述目前管理心脏代谢风险的方法.
- 突出未来研究和临床干预的领域.
结论:
- 尽量减少心脏代谢疾病负担对于改善肝移植接受者的结果至关重要.
- 需要有针对性的干预措施来降低肝移植后代谢综合征和心血管疾病患者的死亡率.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...


